Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target that could be edited to treat sickle ...

The market opportunities for SLE and LN lie in developing targeted therapies, guided by an understanding of epidemiological trends across major markets. Focus on age, sex, and severity can enhance ...

Africa accounts for the majority of global births affected by the condition, yet universal newborn screening remains rare.

Case-cohort study designs represent a cost-effective and efficient strategy for analysing time-to-event data, particularly when the event of interest is rare. By selecting a random subcohort along ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Chatbots may worsen delusions in people by reinforcing false beliefs, psychiatrists warn. Mental health experts document ...

The risk of shingles jumps 11-fold after the first dose of the recombinant shingles vaccine, marketed under the name name Shingrix, but decreases by 73% after the second, according to the results of a ...

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...

Much has been written advising laypeople to navigate conflicting medical opinions and identify the golden truth amid the ...

A simple stool sample may hold a clearer record of what you eat than a food diary ever could. In a new study, researchers ...

Some tech companies, seeking to increase productivity, now offer free nicotine pouches to employees. Can nicotine actually ...